Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Free Cash Flow: 2009-2025

Historic Free Cash Flow for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to -$237,598.

  • China Pharma Holdings' Free Cash Flow fell 529.70% to -$237,598 in Q3 2025 from the same period last year, while for Sep 2025 it was $122,692, marking a year-over-year increase of 116.98%. This contributed to the annual value of -$538,411 for FY2024, which is 24.30% up from last year.
  • Per China Pharma Holdings' latest filing, its Free Cash Flow stood at -$237,598 for Q3 2025, which was down 181.00% from $293,323 recorded in Q2 2025.
  • China Pharma Holdings' 5-year Free Cash Flow high stood at $939,831 for Q3 2023, and its period low was -$1.4 million during Q1 2023.
  • For the 3-year period, China Pharma Holdings' Free Cash Flow averaged around -$116,739, with its median value being -$72,726 (2024).
  • In the last 5 years, China Pharma Holdings' Free Cash Flow surged by 2,911.59% in 2023 and then tumbled by 529.70% in 2025.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Free Cash Flow stood at -$205,168 in 2021, then spiked by 398.22% to $611,862 in 2022, then slumped by 104.39% to -$26,850 in 2023, then spiked by 790.10% to $185,291 in 2024, then crashed by 529.70% to -$237,598 in 2025.
  • Its last three reported values are -$237,598 in Q3 2025, $293,323 for Q2 2025, and -$118,324 during Q1 2025.